Kaneda Y - Search Results

1

Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response.

Uchiyama A, Hoon DS, Morisaki T, Kaneda Y, Yuzuki DH, Morton DL. Uchiyama A, et al. Among authors: kaneda y. Cancer Res. 1993 Mar 1;53(5):949-52. Cancer Res. 1993. PMID: 8439968

2

Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.

Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD, Hoon DS. Okamoto T, et al. Among authors: kaneda y. Gene Ther. 1997 Sep;4(9):969-76. doi: 10.1038/sj.gt.3300490. Gene Ther. 1997. PMID: 9349434

3

Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.

Yamano T, Kaneda Y, Hiramatsu SH, Huang S, Tran AN, Giuliano AE, Hoon DS. Yamano T, et al. Among authors: kaneda y. Cancer Gene Ther. 2007 May;14(5):451-9. doi: 10.1038/sj.cgt.7701035. Epub 2007 Feb 23. Cancer Gene Ther. 2007. PMID: 17318199

4

RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.

Zhou WZ, Hoon DS, Huang SK, Fujii S, Hashimoto K, Morishita R, Kaneda Y. Zhou WZ, et al. Among authors: kaneda y. Hum Gene Ther. 1999 Nov 1;10(16):2719-24. doi: 10.1089/10430349950016762. Hum Gene Ther. 1999. PMID: 10566900

5

Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.

Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D. Zhou WZ, et al. Among authors: kaneda y. Gene Ther. 1999 Oct;6(10):1768-73. doi: 10.1038/sj.gt.3300998. Gene Ther. 1999. PMID: 10516727

6

DNA vaccines for cancer treatment.

Kaneda Y, Hoon DS. Kaneda Y, et al. IDrugs. 2001 Mar;4(3):301-11. IDrugs. 2001. PMID: 16025391 No abstract available.

7

Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy.

Kanyama H, Tomita N, Yamano T, Aihara T, Miyoshi Y, Ohue M, Sekimoto M, Sakita I, Tamaki Y, Kaneda Y, Senter PD, Monden M. Kanyama H, et al. Among authors: kaneda y. Cancer Res. 2001 Jan 1;61(1):14-8. Cancer Res. 2001. PMID: 11196152

8

Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities.

Ishibashi H, Nakagawa K, Onimaru M, Castellanous EJ, Kaneda Y, Nakashima Y, Shirasuna K, Sueishi K. Ishibashi H, et al. Among authors: kaneda y. Cancer Res. 2000 Nov 15;60(22):6531-6. Cancer Res. 2000. PMID: 11103824

9

Detection of peritoneal micrometastases of gastric carcinoma with green fluorescent protein and carcinoembryonic antigen promoter.

Kaneko K, Yano M, Yamano T, Tsujinaka T, Miki H, Akiyama Y, Taniguchi M, Fujiwara Y, Doki Y, Inoue M, Shiozaki H, Kaneda Y, Monden M. Kaneko K, et al. Among authors: kaneda y. Cancer Res. 2001 Jul 15;61(14):5570-4. Cancer Res. 2001. PMID: 11454709

10

Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.

Aragane Y, Maeda A, Cui CY, Tezuka T, Kaneda Y, Schwarz T. Aragane Y, et al. Among authors: kaneda y. J Invest Dermatol. 2000 Dec;115(6):1008-14. doi: 10.1046/j.1523-1747.2000.00164.x. J Invest Dermatol. 2000. PMID: 11121134 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,114 results

Search Page

Filters